CD8A and psoriasis: Additionally, dihydroartemisinin but not methotrexate reduced the presence of CD8+ CLA+, CD8+ CD69+ and CD8+ CD103+ TRM cells in mouse skin and reduced human CD8+ CD103+ TRM cells in humanized mice skin [59], indicating that novel treatments might affect the TRMs and possibly modify the course of psoriasis.